Crossmark

Azacytidine and Venetoclax as a Salvage Therapy for Relapsed/Refractory Acute Myeloid Leukemia: A Single Centre Experience

Published Online: 2024-06-18

Published Print: 2025-01

Authors

Mondal, Saikat

Gupta, Deepika

Vairamoorthy, Naveen

Moule, Priyanka

Kotwal, Jyoti

Gupta, Nitin https://orcid.org/0000-0001-9075-5156
License Information

Text and Data Mining valid from 2024-06-18

Version of Record valid from 2024-06-18
More Information

Article History

Received: 4 March 2024

Accepted: 3 June 2024

First Online: 18 June 2024

Declarations

:

: No competing interests to disclose.

Document is current